CDC Director Walensky to reorganize agency after admitting Covid pandemic response fell short

CDC Director Walensky to reorganize agency after admitting Covid pandemic response fell short


Rochelle Walensky, MD, MPH, Director, United States Centers for Disease Control and Prevention; speaks during the COVID Federal Response Hearing on Capitol Hill on June 16, 2022 in Washington, DC.

Joe Raedle | Getty Images

CDC Director Rochelle Walensky is reorganizing the agency, saying it didn’t react quickly enough during the Covid pandemic, according an internal review of the agency’s operations released on Wednesday.

Walensky laid out several organizational changes the Centers for Disease Control and Prevention will take over the coming months to correct missteps and failures that occurred during the last 2.5 years of the pandemic, according to a fact sheet.

“For 75 years, CDC and public health have been preparing for COVID-19, and in our big moment, our performance did not reliably meet expectations,” Walensky said in a statement.  ”My goal is a new, public health action-oriented culture at CDC that emphasizes accountability, collaboration, communication, and timeliness.”

The central objectives of the reorganization are focused on sharing scientific data faster and making it easier for the public to understand health guidance, according to the briefing document. Walensky launched the review in April after the massive winter surge of infections from the omicron variant upended the nation’s public health response.

The CDC repeatedly faced criticism during the pandemic for confusing public health recommendations and releasing data too slowly through retrospective reports that were outpaced by the rapid spread of the virus. Public health experts were often frustrated that briefings on the pandemic relied on data from other countries, such as the United Kingdom and Israel.

Walensky is appointing an executive to lead a team that will implement changes. The CDC will also create a new executive council that reports directly to Walensky to determine the agency’s key priorities backed up by budget decisions.

The agency’s science and laboratory sciences divisions, which play crucial roles in investigating and tracking public health threats such as Covid, will also report to the CDC director.

The CDC is also creating an equity office to make sure agency’s workforce reflects the U.S. population and better communicates public health guidance across all groups.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

JPMorgan’s top biotech and pharma picks for the second half
Health

JPMorgan’s top biotech and pharma picks for the second half

Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]

Read More
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Read More